Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | NASDAQ | Biotechnology | $41.72B | $376.63 | 2.96% | $318.03M | 7,532.60x | 0.85 | Cayman Islands | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $7.90B | $75.12 | -0.56% | $65.98M | 75.12x | 0.30 | United States | ||
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $215.33B | $48.46 | 0.41% | $24.81B | 13.48x | 2.02 | Denmark | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | $60.84B | $460.54 | 2.53% | $151.92M | 1,485.61x | 19.74 | United States | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | NYSEMKT | Biotechnology | $178.54M | $2.22 | -6.72% | $8.87M | 31.71x | 0.56 | Israel | ||
| ZVRA | ZEVRA THERAPEUTICS INC | NASDAQ | Biotechnology | $516.81M | $9.18 | 3.38% | $67.21M | 19.13x | 1.03 | United States | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | NASDAQ | Biotechnology | $3.14B | $41.40 | 2.68% | $53.58M | 84.49x | 0.33 | Bermuda | ||
| ARGX | ARGENX SE | NASDAQ | Biotechnology | $56.74B | $929.61 | 2.38% | $811.30M | 37.15x | 0.18 | Belgium | ||
| LGND | LIGAND PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.96B | $201.35 | 0.24% | $103.01M | 87.16x | 0.55 | United States | ||
| GMAB | GENMAB A | NASDAQ | Biotechnology | $19.53B | $30.42 | 0.53% | $2.00B | 12.98x | 0.22 | Denmark | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.99B | $39.43 | -1.08% | $29.31M | 151.65x | 0.41 | United States | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $6.04B | $208.25 | 1.01% | $193.29M | 30.18x | 0.09 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $9.13B | $58.61 | -1.30% | $220.90M | 117.22x | 0.29 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $22.60B | $39.16 | 0.00% | $1.04B | 22.25x | 1.01 | United States | ||
| CRMD | CORMEDIX INC | NASDAQ | Biotechnology | $786.31M | $9.98 | -11.21% | $112.26M | 4.40x | 1.01 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $8.30B | $70.56 | 0.76% | $845.48M | 14.43x | 3.41 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $1.05B | $7.10 | -3.79% | $69.21M | 25.36x | 0.34 | United States | ||
| GYRE | GYRE THERAPEUTICS INC | NASDAQ | Biotechnology | $772.59M | $8.02 | 0.38% | $13.23M | 114.57x | 0.22 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $3.11B | $39.28 | -0.18% | $57.00M | 100.72x | 0.09 | United States | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $10.46B | $54.46 | -0.49% | $772.70M | 20.02x | 0.26 | United States | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $110.12B | $434.02 | -0.72% | $4.66B | 30.33x | 0.44 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $20.45B | $104.17 | 0.02% | $1.68B | 17.25x | 0.36 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $3.67B | $15.42 | -0.90% | $172.13M | 17.52x | 0.32 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $1.96B | $33.99 | -0.12% | $269.64M | 10.52x | 0.45 | United States | ||
| INVA | INNOVIVA INC | NASDAQ | Biotechnology | $1.64B | $21.97 | -1.26% | $214.76M | 11.62x | 0.42 | United States | ||
| AUPH | AURINIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.04B | $15.49 | 0.91% | $103.52M | 26.71x | 0.44 | Canada | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $11.37B | $42.42 | 1.85% | $927.60M | 17.24x | 0.31 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.53B | $4.98 | -1.58% | $73.18M | 49.80x | -12.10 | United States | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $74.02B | $704.31 | 1.56% | $5.71B | 16.21x | 0.30 | United States | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $20.32B | $471.92 | 1.18% | $1.77B | 16.57x | 0.12 | United States | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.77B | $22.56 | -2.67% | $323.88M | 12.60x | 0.14 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.